Skip to main content
Springer logoLink to Springer
. 2023 Jul 24;113(3):357–358. doi: 10.1007/s00223-023-01114-y

Correction: Biochemical Markers of Musculoskeletal Health and Aging to be Assessed in Clinical Trials of Drugs Aiming at the Treatment of Sarcopenia: Consensus Paper from an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the Centre Académique de Recherche et d'Expérimentation en Santé (CARES SPRL), Under the Auspices of the World Health Organization Collaborating Center for the Epidemiology of Musculoskeletal Conditions and Aging

Aurélie Ladang 1,✉,#, Charlotte Beaudart 2,#, Jean-Yves Reginster 2,3, Nasser Al-Daghri 3, Olivier Bruyère 2, Nansa Burlet 2, Matteo Cesari 4,5, Antonio Cherubini 6, Mario Coelho da Silva 7, Cyrus Cooper 8, Alfonso J Cruz-Jentoft 9, Francesco Landi 10, Andrea Laslop 11, Stefania Maggi 12, Ali Mobasheri 2,13,14,15, Sif Ormarsdottir 16, Régis Radermecker 17, Marjolein Visser 18, Maria Concepcion Prieto Yerro 19, René Rizzoli 20,#, Etienne Cavalier 1,#
PMCID: PMC10449976  PMID: 37488204

Correction: Calcifed Tissue International (2023) 112:197–217 https://doi.org/10.1007/s00223-022-01054-z

In the article, the affiliation of one of the co-author Antonio Cherubini was incorrect. The correct affiliation is as follows: “Geriatria, Accettazione geriatrica e Centro di ricerca per l’invecchiamento, IRCCS INRCA, Ancona, Italy”.

This has been corrected with this correction.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Aurélie Ladang and Charlotte Beaudart have equally contributed co-primary authors.

René Rizzoli and Etienne Cavalier have equally contributed co-last/senior authors.


Articles from Calcified Tissue International are provided here courtesy of Springer

RESOURCES